Today’s Solutions: August 15, 2026

Breast cancer research just had a major breakthrough, and it was completely unexpected. Doctors at the Institute of Cancer Research in London tested a pair of drugs targeting a specific weakness found in one-in-ten breast cancers on 257 women, and were stunned when they found that the cancer had disappeared or shrunken dramatically in many of the women. What’s even more incredible is that these results came 11 days after the trial had started. In 11 percent of the cases the cancer had completely disappeared, and in a further 17 percent they were smaller than 5mm. The drugs were lapantinib and trastuzumab, which both target HER2 – a protein that fuels the growth of some women’s cancers.

Solutions News Source Print this article
More of Today's Solutions

What’s healthier? Toasted or untoasted bread?

Choosing to toast bread is typically a matter of taste and texture, but did you know that toasting (and dehydrating) your bread might actually ...

Read More

Universal cancer immunotherapy may be possible through protein engineering

Scientists at ETH Zurich have made significant progress in developing a ready-to-use immunotherapy treatment for cancer. A synthetic protein modification can allow immune cells ...

Read More

Flora, fauna, and funga! UN advocates for new turn of phrase in conservation ...

The United Nations Convention on Biological Diversity (UNCBD) argued for the inclusion of fungi in conservation debates alongside flora and fauna so that fungi ...

Read More

New CFBP regulations erase medical debt from credit reports

BY THE OPTIMIST DAILY EDITORIAL TEAM In a bold move to protect consumers burdened by medical debt, the Consumer Financial Protection Bureau (CFPB) unveiled ...

Read More